Often, people confuse antioxidants with metabolic stimulants
SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis
19 The researchers looked at records of over 3.8 million patients who had type 2 diabetes to assess the time to development of NAION after initiation of GLP-1 treatment
Lee SH, Barnes WG, Schaetzel WP
For a broader look at this delivery method across formulas, the Liposomal Collection is a useful reference
Bolger, Albert Licollari, Amin Tan, Richard Greil, Brigitta Vcelar, Sigrun Greil-Ressler, Lukas Weiss, Charlotte Schnlieb, Teresa Magnes, Bianca Radl, Muhammed Majeed, Peter P